These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 20193323)
1. [Great attention should be paid to the adverse drug reactions associated with the use of molecular targeted anticancer drugs]. Chen ZT; Duan YZ; Xu JC Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):881-4. PubMed ID: 20193323 [No Abstract] [Full Text] [Related]
2. Targeted cancer. These "smart weapons" hit cancer in novel ways. Held-Warmkessel J Nursing; 2008 Sep; 38(9):26-32. PubMed ID: 18719487 [TBL] [Abstract][Full Text] [Related]
3. Understanding, recognizing, and managing toxicities of targeted anticancer therapies. Dy GK; Adjei AA CA Cancer J Clin; 2013; 63(4):249-79. PubMed ID: 23716430 [TBL] [Abstract][Full Text] [Related]
4. Catastrophic tumour lysis syndrome following single dose of imatinib. Keane C; Henden A; Bird R Eur J Haematol; 2009 Mar; 82(3):244-5. PubMed ID: 19067739 [No Abstract] [Full Text] [Related]
5. [Optimally spaced after-treatment with multiplicative effect. A cancer therapy principle of universal character]. von Ardenne M Arch Geschwulstforsch; 1973; 42(4):324-44. PubMed ID: 4371114 [No Abstract] [Full Text] [Related]
6. A new probe for targeting drug delivery system. Yu Z; Wang B; Sui J; Feng Y; Zheng C Med Hypotheses; 2009 Jan; 72(1):43-4. PubMed ID: 18829175 [TBL] [Abstract][Full Text] [Related]
7. Progress towards personalized medicine. Bates S Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397 [TBL] [Abstract][Full Text] [Related]
9. Is there a case for selectively promiscuous anticancer drugs? Fernández A; Crespo A; Tiwari A Drug Discov Today; 2009 Jan; 14(1-2):1-5. PubMed ID: 19038361 [TBL] [Abstract][Full Text] [Related]
17. A new classification system of anticancer drugs - based on cell biological mechanisms. Wu XZ Med Hypotheses; 2006; 66(5):883-7. PubMed ID: 16414204 [TBL] [Abstract][Full Text] [Related]
18. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia. Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295 [No Abstract] [Full Text] [Related]
19. Tumour lysis syndrome: new territory for a familiar foe? Graves E; Culligan D Br J Haematol; 2015 Jun; 169(5):609-10. PubMed ID: 25824526 [No Abstract] [Full Text] [Related]
20. [Cancer and electrolytes imbalance]. Shibata H Gan To Kagaku Ryoho; 2010 Jun; 37(6):1006-10. PubMed ID: 20567101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]